149 related articles for article (PubMed ID: 34410186)
1. Electroretinographic Findings in Melanoma-Associated Retinopathy Treated by Intravitreal Dexamethasone Implant.
Abou-Samra A; Tzekov R; Yannuzzi NA; Tarabishy AB
Ophthalmic Surg Lasers Imaging Retina; 2021 Aug; 52(8):454-456. PubMed ID: 34410186
[TBL] [Abstract][Full Text] [Related]
2. Outcomes Associated With Sustained-Release Intraocular Fluocinolone Implants in a Case of Melanoma-Associated Retinopathy Treated Without Systemic Immunosuppression.
Karatsai E; Robson AG; Taylor SRJ
JAMA Ophthalmol; 2019 May; 137(5):564-567. PubMed ID: 30896772
[TBL] [Abstract][Full Text] [Related]
3. Melanoma-associated retinopathy with anti-TRPM1 autoantibodies showing concomitant Off-bipolar cell dysfunction.
Hung WC; Cheng HC; Wang AG
Doc Ophthalmol; 2022 Dec; 145(3):263-270. PubMed ID: 36173494
[TBL] [Abstract][Full Text] [Related]
4. Melanoma-associated retinopathy during pembrolizumab treatment probably controlled by intravitreal injections of dexamethasone.
Poujade L; Samaran Q; Mura F; Guillot B; Meunier I; Du-Thanh A
Doc Ophthalmol; 2021 Apr; 142(2):257-263. PubMed ID: 32975694
[TBL] [Abstract][Full Text] [Related]
5. SAFETY AND FEASIBILITY OF A NOVEL 25-GAUGE BIODEGRADABLE IMPLANT OF DEXAMETHASONE FOR TREATMENT OF MACULAR EDEMA ASSOCIATED WITH RETINAL VEIN OCCLUSION: A PHASE I CLINICAL TRIAL.
Cunha RB; Siqueira RC; Messias A; Scott IU; Fialho SL; Cunha-Junior ADS; Jorge R
Retin Cases Brief Rep; 2018 Winter; 12(1):50-58. PubMed ID: 27632583
[TBL] [Abstract][Full Text] [Related]
6. A case of melanoma-associated retinopathy with autoantibodies against TRPM1.
Kim MS; Hong HK; Ko YJ; Park KH; Ueno S; Okado S; Woo SJ; Joo K
Doc Ophthalmol; 2020 Dec; 141(3):313-318. PubMed ID: 32472235
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal Dexamethasone Implant with Plasma Autoantibody Monitoring for Cancer-associated Retinopathy.
Kim MS; Hong HK; Park KH; Woo SJ
Korean J Ophthalmol; 2019 Jun; 33(3):298-300. PubMed ID: 31179664
[No Abstract] [Full Text] [Related]
8. Human melanoma-associated retinopathy (MAR) antibodies alter the retinal ON-response of the monkey ERG in vivo.
Lei B; Bush RA; Milam AH; Sieving PA
Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):262-6. PubMed ID: 10634629
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal dexamethasone implant use as first-line therapy for cancer-associated retinopathy.
Mudri J; Phagura RS; Lam WS; Wu XN
BMJ Case Rep; 2021 Nov; 14(11):. PubMed ID: 34764094
[TBL] [Abstract][Full Text] [Related]
10. INTRAVITREAL DEXAMETHASONE (OZURDEX) IMPLANT FOR RADIATION MACULOPATHY SECONDARY TO STEREOTACTIC RADIOTHERAPY FOR POSTERIOR UVEAL MELANOMA.
Koc I; Kadayifcilar S; Kiratli H; Eldem B
Retin Cases Brief Rep; 2019; 13(4):352-356. PubMed ID: 28489707
[TBL] [Abstract][Full Text] [Related]
11. DEXAMETHASONE INTRAVITREAL IMPLANT FOR X-LINKED (JUVENILE) RETINOSCHISIS.
Mukhtar S; Potter SM; Khurshid SG
Retin Cases Brief Rep; 2019 Winter; 13(1):18-20. PubMed ID: 30562235
[TBL] [Abstract][Full Text] [Related]
12. Short-Term Assessment of Intravitreal Dexamethasone Implant Using Enhanced-Depth Image Optical Coherence Tomography and Optical Coherence Tomography Angiography in Patients with Retinal Vascular Diseases.
Minnella AM; Federici M; Pagliei V; Lanza A; Gambini G; Caputo CG; Falsini B; Caporossi A
Adv Ther; 2019 Feb; 36(2):416-425. PubMed ID: 30565180
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal dexamethasone implant in radiation-induced macular oedema.
Frizziero L; Parrozzani R; Trainiti S; Pilotto E; Miglionico G; Pulze S; Midena E
Br J Ophthalmol; 2017 Dec; 101(12):1699-1703. PubMed ID: 28404670
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Acute Zonal Occult Outer Retinopathy With Intravitreal Steroids.
Barnes AC; Lowder CY; Bessette AP; Baynes K; Srivastava SK
Ophthalmic Surg Lasers Imaging Retina; 2018 Jul; 49(7):504-509. PubMed ID: 30021037
[TBL] [Abstract][Full Text] [Related]
15. SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.
Coscas G; Coscas F; Zucchiatti I; Glacet-Bernard A; Soubrane G; Souïed E
Eur J Ophthalmol; 2011; 21(5):631-6. PubMed ID: 21500185
[TBL] [Abstract][Full Text] [Related]
16. Delayed presentation of melanoma-associated retinopathy and subsequent resolution with cytoreduction surgery.
Stead RE; Fox MA; Staples E; Lim CS
Doc Ophthalmol; 2013 Oct; 127(2):165-71. PubMed ID: 23794161
[TBL] [Abstract][Full Text] [Related]
17. Acute retinal necrosis following dexamethasone intravitreal implant (Ozurdex®) administration in an immunocompetent adult with a history of HSV encephalitis: a case report.
Zhang ZY; Liu XY; Jiang T
BMC Ophthalmol; 2020 Jun; 20(1):247. PubMed ID: 32571253
[TBL] [Abstract][Full Text] [Related]
18. Impact of intravitreal dexamethasone implant (Ozurdex) on macular morphology and function.
Querques G; Lattanzio R; Querques L; Triolo G; Cascavilla ML; Cavallero E; Del Turco C; Casalino G; Bandello F
Retina; 2014 Feb; 34(2):330-41. PubMed ID: 23945638
[TBL] [Abstract][Full Text] [Related]
19. INTRAVITREAL DEXAMETHASONE IMPLANT FOR RADIATION MACULOPATHY SECONDARY TO PLAQUE BRACHYTHERAPY IN CHOROIDAL MELANOMA.
Caminal JM; Flores-Moreno I; Arias L; Gutiérrez C; Piulats JM; Català J; Rubio MJ; Cobos E; García P; Pera J; Giralt J; Arruga J
Retina; 2015 Sep; 35(9):1890-7. PubMed ID: 26035401
[TBL] [Abstract][Full Text] [Related]
20. The Structural and Comparative Analysis of Intravitreal Dexamethasone Implant (Ozurdex) and Anti-VEGF Injection in Branched Retinal Vein Occlusion Patients by Optical Coherence Tomography Angiography Images Quantitation.
Park JH; Kim EC
Semin Ophthalmol; 2021 Oct; 36(7):475-481. PubMed ID: 33843438
[No Abstract] [Full Text] [Related]
[Next] [New Search]
